Pictet Asset Management
JAZZ icon

Pictet Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pictet Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.8M Sell
173,250
-11,446
-6% -$2M 0.03% 395
2025
Q4 		$31.5M Sell
184,696
-33,547
-15% -$5.14M 0.03% 414
2025
Q3 		$28.2M Sell
218,243
-8,592
-4% -$1.03M 0.03% 447
2025
Q2 		$24.2M Buy
226,835
+19,195
+9% +$2.09M 0.02% 463
2025
Q1 		$25.5M Sell
207,640
-4,080
-2% -$532K 0.03% 434
2024
Q4 		$26.1M Sell
211,720
-13,495
-6% -$1.59M 0.03% 429
2024
Q3 		$25M Sell
225,215
-13,706
-6% -$1.5M 0.03% 429
2024
Q2 		$25.5M Sell
238,921
-308,834
-56% -$34M 0.03% 405
2024
Q1 		$66M Sell
547,755
-30,442
-5% -$3.73M 0.07% 263
2023
Q4 		$71.1M Buy
578,197
+102,129
+21% +$12.7M 0.08% 250
2023
Q3 		$61.6M Buy
+476,068
New +$63.4M 0.08% 259

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Pictet Asset Management's JAZZ Position: Q1 2026 in Review

Pictet Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 6.2% in Q1 2026, selling an estimated $2M and leaving 173,250 shares worth $31.8M. The position accounts for 0.03% of the portfolio, ranked #395.

Pictet Asset Management first reported a position in JAZZ in Q3 2023 and has held it in 11 quarters since. The position peaked at $71.1M in Q4 2023. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Pictet Asset Management held 173,250 shares of Jazz Pharmaceuticals worth $31.8M as of Q1 2026.
  • Pictet Asset Management sold 11,446 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2M.
  • Jazz Pharmaceuticals made up 0.03% of Pictet Asset Management's portfolio in Q1 2026, its #395 holding.
  • Pictet Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Jazz Pharmaceuticals position peaked at $71.1M in Q4 2023.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.